| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |